Showing 1 - 10 of 11
As in most industrialized countries, the inequality regarding the distribution of household incomes in Germany has steadily increased. By collecting taxes and granting monetary transfers, the government tries to affect the personal distribution of incomes. Whereas the supply of redistribution is...
Persistent link: https://www.econbiz.de/10011199883
In many countries, policy makers try to increase quality and efficiency in the hospital sector by fostering competition. The German hospital market is a good example of this approach and the challenges that come with it. We focus on market concentration which is both a result of and a potential...
Persistent link: https://www.econbiz.de/10010617066
Persistent link: https://www.econbiz.de/10010557837
The paper analyses the relationship between health and education in a two period human capital framework. The resulting substitution and investment effects between health and advanced training work in opposite direction and leave open questions for the empirical part. As econometric model we use...
Persistent link: https://www.econbiz.de/10008596482
The decision to contact a physician and the decision about how often to contact a physician are determined by different decisionmakers. We introduce a negative binomial distributed hurdle model that specifies the two stages of the decisionmaking process as different stochastic processes, while...
Persistent link: https://www.econbiz.de/10008457708
Persistent link: https://www.econbiz.de/10005678388
It is the purpose of this study to forecast the future development of total expenditures of sickness funds in Germany under the assumption that present institutions remain unchanged. Previous approaches using present age-specific expenditure data are systematically flawed. In contrast, we use...
Persistent link: https://www.econbiz.de/10005027153
Persistent link: https://www.econbiz.de/10001451506
Abstract: Die wirtschaftliche Globalisierung und die Alterung der Bevölkerung stellen die öffentlichen Haushalte wie auch die Systeme der sozialen Sicherung vor enorme Herausforderungen. Vor diesem Hintergrund unternehmen die Autoren der vorliegenden Festschrift, die unterschiedlichen...
Persistent link: https://www.econbiz.de/10011674689
Seit 2011 markiert das „Arzneimittelmarktneuordnungsgesetz“ (AMNOG) eine Wende bei der Erstattung von neuen patentgeschützten Arzneimitteln. Bis dahin wurde ihr Herstellerabgabepreis ohne jede Nutzenbewertung für die Dauer des Patentschutzes erstattet. Nun ist dies auf maximal ein Jahr...
Persistent link: https://www.econbiz.de/10012015262